Oxygenation Efficacy of "Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-22

Study Completion Date

2025-05-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on early bench-testing data and subsequent clinical case studies in the U.S., "Intrinseque Health" non-rebreathing mask (IHNRM) has delivered virtual elimination of air entrainment and preferential delivery of all available oxygen first into the alveolar spaces by sequential opening of valves in its controller manifold, even at oxygen flow as low as 10 LPM, patient can attain high alveolar oxygen concentration of 75% or more-far higher than attainable with face mask or nasal cannula.

Numerous intubated patients emerging from the operating room require intensive critical care specialist supervision in order to transition to the regular care. This would enable higher patient turnover and more efficient utilization of hospital resources, if patient can be transited to the regular care earlier by using a device that supports high oxygenation. This will enable a faster, safe and smooth extubation in critical care, and earlier discharge from intensive care ward.

This study is anticipated to take only around 2.5 hour per patient to complete. Patients meeting the inclusion and exclusion criteria of this study are placed on IHNRM and monitored until steady state of SpO2 of 95% or higher on 7-10 LPM has been maintained for at least 2 hours, when they can be discharged from the post-anesthesia care unit (PACU) to the regular care ward.

The study is the parallel design study. 60 patients will be randomly selected to use the IHNRM, and 30 subjects will be placed on HFNC. Blood oxygen concentration (SpO2), respiratory rate, end tidal CO2 concentration (EtCO2), and vital sign will be recorded in the study. The endpoint of the study is to compare the effect after using between "IHNRM" and HFNC.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of HVNI in Severe Chest Trauma

NCT05692076

Chest Trauma

UNKNOWN NA

Comparison of Different Oxygen Flow Rates During Preoxygenation Using High-Flow Nasal Oxygen

NCT06736132

Airway Anesthesia Preoxygenation High Flow Nasal Canula

ACTIVE_NOT_RECRUITING NA

High Flow Nasal Oxygen Therapy for Hypoxemy After Cardiac Surgery

NCT01617252

Hypoxemic Acute Respiratory Failure

COMPLETED NA

Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples

NCT01638455

Various Comorbidities

COMPLETED NA

Effects of Blood Flow of Venoarterial Extracorporeal Membrane Oxygenation Life Support on Microcirculation

NCT03210818

Circulatory Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Disease Respiratory Distress Syndrome Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Flow Nasal Cannula

Group Type ACTIVE_COMPARATOR

High Flow Nasal Cannula

Intervention Type DEVICE

High Flow Nasal Cannula

"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Group Type EXPERIMENTAL

"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Intervention Type DEVICE

"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Flow Nasal Cannula

Intervention Type DEVICE

"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ANY hospitalized patient in moderate to moderately severe respiratory distress and able to breathe spontaneously, and with SpO2 (oxygen saturation by pulse oximetry) reading of:

(i) 90% or less on room air, or (ii) \<95% in spite of oxygen supplementation on another form of oxygen supplementation.
2. Has minimum ideal body wt. of at least ≥15 kg., and at least 3 years old.
3. Self/guardian-able to consent to study participation and monitoring.

Exclusion Criteria

Patient with any of the following present will be excluded:

1. Agitated or confused or somnolent mental state.
2. Any impairment of gag reflex.
3. Multi-organ failure that may decompensate rapidly, with or without hypoperfusion secondary to cardiogenic, hypovolemic, or septic shock.
4. Acute MI, pulmonary embolism, pneumothorax or stroke
5. Inability to pull mask off (or to side of) face in emergency.
6. ICP (intracranial pressure) \> 15mmhg. If ICP unknown but clinically may have elevated ICP (such as head trauma or CNS tumor), patient should be excluded.

Minimum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No